Elsevier

Schizophrenia Research

Volume 70, Issues 2–3, 1 October 2004, Pages 315-329
Schizophrenia Research

Meta-analysis of the P300 and P50 waveforms in schizophrenia

https://doi.org/10.1016/j.schres.2004.01.004Get rights and content

Abstract

Objective: To determine whether patients with schizophrenia have abnormalities in the P300 and P50 waves and to quantify the magnitude of any differences from controls. Method: We conducted a systematic search for articles published between January 1994 and August 2003 that reported P50 or P300 measures in schizophrenic patients and controls. Metaregression analyses were performed using a random effects model. The pooled standardised effect size (PSES) was calculated as the difference between the means of the two groups divided by the common standard deviation. Results: We identified 46 studies suitable for analysis of P300 measures, including 1443 patients and 1251 controls. There were 20 P50 studies including 421 patients and 401 controls. The PSES for the P300 amplitude was 0.85 (95% CI: 0.65 to 1.05; p<0.001), and for the P300 latency was −0.57 (95% CI: −0.75 to −0.38; p<0.001). The PSES of the P50 ratio was −1.56 (95% CI: −2.05 to −1.06; p<0.001). There were no significant differences between patients and controls in P50 latency. Across-study variations in filters, task difficulty, antipsychotic medication and duration of illness did not influence the PSES significantly. Conclusions: This meta-analysis confirms the existence of ERP deficits in schizophrenia. The magnitude of these deficits is similar to the most robust findings reported in neuroimaging and neuropsychology in schizophrenia.

Introduction

Event related potentials (ERPs) are changes in the electrophysiological activity of the brain, which occur in response to stimuli. The P300 waveform has been conceptualised as the physiological correlate of a working memory update of changes in the environment (Donchin and Coles, 1988) or as an index of allocation of attentional resources (Posner, 1975). The P50 suppression (a decrease in the P50 amplitude in response to the second of two paired auditory stimuli) is thought to reflect a sensory gating mechanism, aimed at protecting against information overload Freedman et al., 1987, Braff and Geyer, 1990, Freedman et al., 1996. In the last 10 years alone, over 100 journal articles on the P300 in schizophrenia and over 75 on the P50 have been published. Although the majority of studies coincide in finding P300 amplitude reductions in schizophrenia, results are less consistent for the P300 latency and the P50 measures. There are a number of methodological reasons for the discrepancies reported. Many of the results have not been corrected for age, gender and drug treatment, and differences in technical aspects could also account for some of the differences found. Importantly, most studies report their results with an emphasis on significance tests rather than confidence intervals, and this may give the misleading impression of a large number of inconsistent positive or negative findings.

Much of this work has been fuelled by the hope that abnormalities in the P300 or P50 might represent endophenotypes of schizophrenia that could ultimately contribute to our understanding of the genetic basis of the illness (Wickham and Murray, 1997). According to Gottesman and Gould (2003), amongst other criteria, a putative endophenotype should be associated with the illness and should therefore distribute differently between healthy and affected individuals. We set out to address the question of whether P300 and P50 phenotypes fulfil this fundamental requirement, and to quantify the magnitude of any differences in the waveforms between patients and healthy volunteers.

Section snippets

Method

We carried out computer searches of the databases MEDLINE and SCIENCE CITATION INDEX. We searched the databases for papers published between January 1994 and August 2003 using the following Medical Subject Heading (MeSH) categories: P300 AND [Psychosis OR Schizophrenia], P50 AND [Psychosis OR Schizophrenia] for the P300 and the P50 components, respectively. We also conducted a manual search of papers published between January and August 2003 in the following journals: American Journal of

Results

We identified 46 studies on the P300 wave that were suitable for analysis. These included a total of 1443 patients with schizophrenia and 1251 controls. For the P50 we identified 20 studies suitable for analysis, which included 421 patients and 401 healthy volunteers. The articles included are described in Table 1, Table 2 and the main results of the meta-analysis are summarised in Table 3. Full details of the data are available upon request from the authors.

How severe are P50/P300 deviances in schizophrenia?

We conclude that patients with schizophrenia have severe deficits in their P50 gating and their P300 amplitude. The mean P50 ratio for patients was 1.56 standard deviations larger than the mean for controls. The P300 amplitude shows a robust decrease in schizophrenia with a standardised effect size of 0.85. This result is in full agreement with findings by Jeon and Polich (2001), who conducted a meta-analysis of the early literature on P300 amplitude topography in schizophrenia. These effect

Conclusion

Our study confirms that patients with schizophrenia have clear P50/P300 abnormalities compared to healthy volunteers. The magnitude of these differences is comparable with the most robust findings reported for brain morphometric and neuropsychological abnormalities in schizophrenia. Longitudinal studies to explore the effect of psychopathology and duration of illness upon neurophysiological markers are now needed.

Acknowledgements

This research was supported by The Wellcome Trust and the Schizophrenia Research Fund. Dr. E. Bramon is a Wellcome Research Training Fellow.

We would like to thank Claude Alain, Douglas Blackwood, Nashaat Boutros, Anke Brockhaus-Dumke, Gerard Bruder, Judith Ford, Robert Freedman, Holger Hill, Yi Jin, Jürgen Kayser, Manuel Martı́n-Loeches, Robert Mccarley, Dorien Nieman, Ann Olincy, Dean Salisbury, Eric Vuurman, Merilyne Waldo, Georg Winterer and Cindy Yee-Bradbury whose helpful correspondence

References (111)

  • B.A. Clementz et al.

    P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis

    Biol. Psychiatry

    (1997)
  • B.A. Clementz et al.

    Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects

    Schizophr. Res.

    (1998)
  • K.L. Coburn et al.

    P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication

    Biol. Psychiatry

    (1998)
  • C. Cullum et al.

    Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia

    Schizophr. Res.

    (1993)
  • J.M. Ford et al.

    P300 amplitude is related to clinical state in severely and moderately ill patients with schizophrenia

    Biol. Psychiatry

    (1999)
  • S. Frangou et al.

    The maudsley family study: II. Endogenous event-related potentials in familial schizophrenia

    Schizophr. Res.

    (1997)
  • T. Frodl-Bauch et al.

    P300 subcomponents reflect different aspects of psychopathology in schizophrenia

    Biol. Psychiatry

    (1999)
  • J. Gallinat et al.

    Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing

    Biol. Psychiatry

    (2003)
  • M.F. Glabus et al.

    Methodological considerations in measurement of the P300 component of the auditory oddball ERP in schizophrenia

    Electroencephalogr. Clin. Neurophysiol.

    (1994)
  • A.S. Gonul et al.

    Effects of olanzapine on auditory P300 in schizophrenia

    Prog. Neuro-Psychopharmacol. Biol. Psychiatry

    (2003)
  • J.M. Griffith et al.

    Normalization of the auditory P50 gating deficit of schizophrenic patients after non-REM but not REM sleep

    Psychiatry Res.

    (1995)
  • Y. Guterman et al.

    Sensory gating deviance in schizophrenia in the context of task related effects

    Int. J. Psychophysiol.

    (1994)
  • P.J. Harrison et al.

    Genes for schizophrenia? Recent findings and their pathophysiological implications

    Lancet

    (2003)
  • H. Hill et al.

    The relation between asymmetry and amplitude of the P300 field in schizophrenia

    Clin. Neurophysiol.

    (1999)
  • M.X. Huang et al.

    Predicting EEG responses using MEG sources in superior temporal gyrus reveals source asynchrony in patients with schizophrenia

    Clin. Neurophysiol.

    (2003)
  • J. Ito et al.

    The P300 event-related potentials in dementia of the Alzheimer type. Correlation between P300 and monoamine metabolites

    Electroencephalogr. Clin. Neurophysiol.

    (1990)
  • Y.W. Jeon et al.

    P300 asymmetry in schizophrenia: a meta-analysis

    Psychiatry Res.

    (2001)
  • Y. Jin et al.

    Effects of P50 temporal variability on sensory gating in schizophrenia

    Psychiatry Res.

    (1997)
  • Y. Jin et al.

    Is P50 suppression a measure of sensory gating in schizophrenia?

    Biol. Psychiatry

    (1998)
  • G. Juckel et al.

    Residual symptoms and P300 in schizophrenic outpatients

    Psychiatry Res.

    (1996)
  • B. Karoumi et al.

    Alteration of event related potentials in siblings discordant for schizophrenia

    Schizophr. Res.

    (2000)
  • A. Laurent et al.

    Auditory event-related potentials and clinical scores in unmedicated schizophrenic patients

    Psychiatry Res.

    (1999)
  • M. Martin-Loeches et al.

    P300 amplitude as a possible correlate of frontal degeneration in schizophrenia

    Schizophr. Res.

    (2001)
  • D.H. Mathalon et al.

    P300 reduction and prolongation with illness duration in schizophrenia

    Biol. Psychiatry

    (2000)
  • D.H. Nieman et al.

    Clinical and neuropsychological correlates of the P300 in schizophrenia

    Schizophr. Res.

    (2002)
  • J. Olichney et al.

    Relationship between auditory P300 amplitude and age of onset of schizophrenia in older patients

    Psychiatry Res.

    (1998)
  • A. Olincy et al.

    The P50 auditory event-evoked potential in adult atttention-deficit disorder: comparison with schizophrenia

    Biol. Psychiatry

    (2000)
  • M. Owen

    Molecular genetic studies of schizophrenia

    Brain Res. Brain Res. Rev.

    (2000)
  • S. Pallanti et al.

    Effects of clozapine on awareness of illness and cognition in schizophrenia

    Psychiatry Res.

    (1999)
  • A. Pfefferbaum et al.

    Clinical applications of the P3 component of event-related potentials: II. Dementia, depression and schizophrenia

    Electroencephalogr. Clin. Neurophysiol.

    (1984)
  • J. Polich

    Task difficulty, probability, and inter-stimulus interval as determinants of P300 from auditory stimuli

    Electroencephalogr. Clin. Neurophysiol.

    (1987)
  • M. Posner
  • D. Salisbury et al.

    P300 topography differs in schizophrenia and manic psychosis

    Biol. Psychiatry

    (1999)
  • V.B.N. Souza et al.

    Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder

    Biol. Psychiatry

    (1995)
  • S.B. Stefansson et al.

    Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication

    Biol. Psychiatry

    (1996)
  • W.K. Strik et al.

    P300 asymmetries in schizophrenia revisited with reference-independent methods

    Psychiatry Res. Neuroimaging

    (1994)
  • B.I. Turetsky et al.

    P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology

    Biol. Psychiatry

    (1998)
  • B.I. Turetsky et al.

    P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands

    Biol. Psychiatry

    (2000)
  • D. Umbricht et al.

    Effects of clozapine on auditory event-related potentials in schizophrenia

    Biol. Psychiatry

    (1998)
  • L. Adler et al.

    Normalisation of auditory physiology by cigarette smoking in schizophrenic patients

    Am. J. Psychiatr.

    (1993)
  • Cited by (491)

    • P300 in schizophrenia: Then and now

      2024, Biological Psychology
    View all citing articles on Scopus
    View full text